Dr. ID: 40302

Sarah Jane Pauline Minner

graph of relations

Publications

  1. 2020
  2. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer

    Freytag, M., Kluth, M., Bady, E., Hube-Magg, C., Makrypidi-Fraune, G., Heinzer, H., Höflmayer, D., Weidemann, S., Uhlig, R., Huland, H., Graefen, M., Bernreuther, C., Wittmer, C., Tsourlakis, M. C., Minner, S., Dum, D., Hinsch, A., Luebke, A. M., Simon, R., Sauter, G., Schlomm, T. & Möller, K., 18.12.2020, In: BMC CANCER. 20, 1, p. 1220

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy

    Soave, A., Kluwe, L., Yu, H., Rink, M., Gild, P., Vetterlein, M. W., Marks, P., Sauter, G., Fisch, M., Meyer, C. P., Ludwig, T., Dahlem, R., Minner, S., Pantel, K., Steinbach, B. & Schwarzenbach, H., 09.12.2020, In: SCI REP-UK. 10, 1, p. 21562

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

    Möller, K., Wecker, A. L., Höflmayer, D., Fraune, C., Makrypidi-Fraune, G., Hube-Magg, C., Kluth, M., Steurer, S., Clauditz, T. S., Wilczak, W., Simon, R., Sauter, G., Huland, H., Heinzer, H., Haese, A., Schlomm, T., Weidemann, S., Luebke, A. M., Minner, S., Bernreuther, C., Bonk, S. & Marx, A., 11.2020, In: VIRCHOWS ARCH. 477, 5, p. 625-636 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. High B7-H3 expression is linked to increased risk of prostate cancer progression

    Bonk, S., Tasdelen, P., Kluth, M., Hube-Magg, C., Makrypidi-Fraune, G., Möller, K., Höflmayer, D., Dwertmann Rico, S., Büscheck, F., Minner, S., Heinzer, H., Graefen, M., Hinsch, A., Luebke, A. M., Dum, D., Uhlig, R., Schlomm, T., Sauter, G., Simon, R. & Weidemann, S. A., 10.2020, In: PATHOL INT. 70, 10, p. 733-742 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions

    Bernreuther, C., Daghigh, F., Möller, K., Hube-Magg, C., Lennartz, M., Lutz, F., Rico, S. D., Fraune, C., Dum, D., Luebke, A. M., Eichenauer, T., Möller-Koop, C., Schlomm, T., Wittmer, C., Huland, H., Heinzer, H., Graefen, M., Haese, A., Burandt, E., Tsourlakis, M. C., Clauditz, T. S., Höflmayer, D., Izbicki, J. R., Simon, R., Sauter, G., Minner, S., Steurer, S. & Meiners, J., 10.2020, In: PATHOL ONCOL RES. 26, 4, p. 2709-2722 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

    Kind, S., Büscheck, F., Höflmayer, D., Hube-Magg, C., Kluth, M., Tsourlakis, M. C., Steurer, S., Clauditz, T. S., Luebke, A. M., Burandt, E., Wilczak, W., Hinsch, A., Dum, D., Weidemann, S., Fraune, C., Beyer, B., Steuber, T., Huland, H., Graefen, M., Fisch, M., Simon, R., Sauter, G., Schlomm, T., Minner, S. & Eichenauer, T., 09.2020, In: WORLD J UROL. 38, 9, p. 2185-2196 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

    Luebke, A. M., Ricken, W., Kluth, M., Hube-Magg, C., Schroeder, C., Büscheck, F., Möller, K., Dum, D., Höflmayer, D., Weidemann, S., Fraune, C., Hinsch, A., Wittmer, C., Schlomm, T., Huland, H., Heinzer, H., Graefen, M., Haese, A., Minner, S., Simon, R., Sauter, G., Wilczak, W. & Meiners, J., 15.07.2020, In: INT J CANCER. 147, 2, p. 575-583 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

    Fraune, C., Yehorov, S., Luebke, A. M., Steurer, S., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Simon, R., Sauter, G., Weidemann, S., Dum, D., Kind, S., Minner, S., Schlomm, T., Huland, H., Heinzer, H., Graefen, M. & Burandt, E., 07.2020, In: PATHOL INT. 70, 7, p. 441-451 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

    Eichenauer, T., Shadanpour, N., Kluth, M., Göbel, C., Weidemann, S., Fraune, C., Büscheck, F., Hube-Magg, C., Möller-Koop, C., Dahlem, R., Fisch, M., Rink, M., Riechardt, S., Burandt, E., Bernreuther, C., Minner, S., Simon, R., Sauter, G., Wilczak, W. & Clauditz, T., 13.06.2020, In: WORLD J SURG ONCOL. 18, 1, p. 128

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

    Eichenauer, T., Federlein, F., Möller, K., Chirico, V., Kind, S., Lennartz, M., Lutz, F., Hube-Magg, C., Höflmayer, D., Fisch, M., Huland, H., Heinzer, H., Graefen, M., Haese, A., Schroeder, C., Lebok, P., Minner, S., Simon, R., Sauter, G., Schlomm, T., Wilczak, W., Steurer, S. & Luebke, A. M., 06.2020, In: PATHOLOGY. 52, 4, p. 421-430 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

    Blessin, N. C., Spriestersbach, P., Li, W., Mandelkow, T., Dum, D., Simon, R., Hube-Magg, C., Lutz, F., Viehweger, F., Lennartz, M., Fraune, C., Nickelsen, V., Fehrle, W., Göbel, C., Weidemann, S., Clauditz, T., Lebok, P., Möller, K., Steurer, S., Izbicki, J. R., Sauter, G., Minner, S., Jacobsen, F., Luebke, A. M., Büscheck, F., Höflmayer, D., Wilczak, W., Burandt, E. & Hinsch, A., 06.2020, In: CELL ONCOL. 43, 3, p. 421-430 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

    Fraune, C., Harms, L., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Simon, R., Möller, K., Luebke, A. M., Möller-Koop, C., Steurer, S., Hube-Magg, C., Sauter, G., Weidemann, S., Lebok, P., Dum, D., Kind, S., Minner, S., Izbicki, J. R., Schlomm, T., Huland, H., Heinzer, H., Burandt, E., Haese, A., Graefen, M. & Schroeder, C., 06.03.2020, In: MOL MED. 26, 1, p. 24

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. High RSF1 protein expression is an independent prognostic feature in prostate cancer

    Höflmayer, D., Hamuda, M., Schroeder, C., Hube-Magg, C., Simon, R., Göbel, C., Hinsch, A., Weidemann, S., Möller, K., Izbicki, J. R., Jacobsen, F., Mandelkow, T., Blessin, N. C., Lutz, F., Viehweger, F., Sauter, G., Burandt, E., Lebok, P., Lennartz, M., Fraune, C., Minner, S., Bonk, S., Huland, H., Graefen, M., Schlomm, T. & Büscheck, F., 03.2020, In: ACTA ONCOL. 59, 3, p. 268-273 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer

    Hennigs, J. K., Minner, S., Tennstedt, P., Löser, R., Huland, H., Klose, H., Graefen, M., Schlomm, T., Sauter, G., Bokemeyer, C. & Honecker, F., 24.02.2020, In: SCI REP-UK. 10, 1, p. 3250

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. 8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

    Eichenauer, T., Bannenberg, D. C., Kluth, M., Wittmer, C., Büscheck, F., Möller, K., Dum, D., Fraune, C., Hube-Magg, C., Möller-Koop, C., Dahlem, R., Fisch, M., Rink, M., Riechardt, S., Tsourlakis, M. C., Bernreuther, C., Minner, S., Simon, R., Sauter, G., Wilczak, W. & Clauditz, T. S., 02.2020, In: UROL ONCOL-SEMIN ORI. 38, 2, p. 43.e13-43.e20

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

    Büscheck, F., Sulimankhil, M., Melling, N., Höflmayer, D., Hube-Magg, C., Simon, R., Göbel, C., Hinsch, A., Weidemann, S., Izbicki, J. R., Jacobsen, F., Mandelkow, T., Blessin, N. C., Möller-Koop, C., Lutz, F., Viehweger, F., Möller, K., Sauter, G., Lennartz, M., Burandt, E., Lebok, P., Minner, S., Bonk, S., Huland, H., Graefen, M., Schlomm, T. & Fraune, C., 02.2020, In: CANCER MED-US. 9, 4, p. 1409-1418 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

    Höflmayer, D., Steinhoff, A., Hube-Magg, C., Kluth, M., Simon, R., Burandt, E., Tsourlakis, M. C., Minner, S., Sauter, G., Büscheck, F., Wilczak, W., Steurer, S., Huland, H., Graefen, M., Haese, A., Heinzer, H., Schlomm, T., Jacobsen, F., Hinsch, A., Poos, A. M., Oswald, M., Rippe, K., König, R. & Schroeder, C., 01.2020, In: MOL ONCOL. 14, 1, p. 129-138 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence

    Kind, S., Kluth, M., Hube-Magg, C., Möller, K., Makrypidi-Fraune, G., Lutz, F., Lennartz, M., Rico, S. D., Schlomm, T., Heinzer, H., Höflmayer, D., Weidemann, S., Uhlig, R., Huland, H., Graefen, M., Bernreuther, C., Tsourlakis, M. C., Minner, S., Dum, D., Hinsch, A., Lübke, A. M., Simon, R., Sauter, G., Marx, A. & Polonski, A., 2020, In: BIOMED RES INT . 2020, p. 5845374

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

    Marx, A., Luebke, A. M., Clauditz, T. S., Steurer, S., Fraune, C., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Möller-Koop, C., Simon, R., Sauter, G., Göbel, C., Lebok, P., Dum, D., Kind, S., Minner, S., Izbicki, J., Schlomm, T., Huland, H., Heinzer, H., Burandt, E., Haese, A., Graefen, M. & Meiners, J., 2020, In: DIS MARKERS. 2020, p. 7050146

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. 2019
  22. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

    Steurer, S., Schwemmer, L., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Luebke, A. M., Simon, R., Sauter, G., Izbicki, J., Schroeder, C., Schlomm, T., Huland, H., Heinzer, H., Haese, A., Graefen, M., Göbel, C., Weidemann, S., Lebok, P., Dum, D., Fraune, C., Minner, S. & Meiners, J., 24.12.2019, In: ONCOTARGET. 10, 67, p. 7096-7111 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Upregulation of SPDEF is associated with poor prognosis in prostate cancer

    Meiners, J., Schulz, K., Möller, K., Höflmayer, D., Burdelski, C., Hube-Magg, C., Simon, R., Göbel, C., Hinsch, A., Reiswich, V., Weidemann, S., Izbicki, J. R., Sauter, G., Jacobsen, F., Möller-Koop, C., Mandelkow, T., Blessin, N. C., Lutz, F., Viehweger, F., Lennartz, M., Fraune, C., Heinzer, H., Minner, S., Bonk, S., Huland, H., Graefen, M., Schlomm, T. & Büscheck, F., 11.2019, In: ONCOL LETT. 18, 5, p. 5107-5118 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Random forest-based modelling to detect biomarkers for prostate cancer progression

    Toth, R., Schiffmann, H., Hube-Magg, C., Büscheck, F., Höflmayer, D., Weidemann, S., Lebok, P., Fraune, C., Minner, S., Schlomm, T., Sauter, G., Plass, C., Assenov, Y., Simon, R., Meiners, J. & Gerhäuser, C., 22.10.2019, In: CLIN EPIGENETICS. 11, 1, p. 148

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

    Weidemann, S. A., Sauer, C., Luebke, A. M., Möller-Koop, C., Steurer, S., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Simon, R., Sauter, G., Göbel, C., Lebok, P., Dum, D., Fraune, C., Kind, S., Minner, S., Izbicki, J., Schlomm, T., Huland, H., Heinzer, H., Burandt, E., Haese, A., Graefen, M. & Heumann, A., 12.10.2019, In: BMC CANCER. 19, 1, p. 944

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

    Steurer, S., Hager, B., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Minner, S., Clauditz, T. S., Hube-Magg, C., Luebke, A. M., Simon, R., Izbicki, J. R., Burandt, E., Sauter, G., Fraune, C., Weidemann, S., Schlomm, T., Heinzer, H., Haese, A., Graefen, M., Huland, H. & Heumann, A., 25.09.2019, In: AGING-US. 11, 18, p. 7859-7879 21 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

    Bonk, S., Kluth, M., Hube-Magg, C., Polonski, A., Soekeland, G., Makropidi-Fraune, G., Möller-Koop, C., Witt, M., Luebke, A. M., Hinsch, A., Burandt, E., Steurer, S., Clauditz, T. S., Schlomm, T., Perez, D., Graefen, M., Heinzer, H., Huland, H., Izbicki, J. R., Wilczak, W., Minner, S., Sauter, G. & Simon, R., 10.09.2019, In: ONCOTARGET. 10, 52, p. 5439-5453 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

    Minner, S., Hager, D., Steurer, S., Höflmayer, D., Tsourlakis, M. C., Möller-Koop, C., Clauditz, T. S., Hube-Magg, C., Luebke, A. M., Simon, R., Sauter, G., Göbel, C., Weidemann, S., Lebok, P., Dum, D., Fraune, C., Izbicki, J., Burandt, E., Schlomm, T., Huland, H., Heinzer, H., Haese, A., Graefen, M. & Heumann, A., 09.2019, In: NEOPLASIA. 21, 9, p. 872-881 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. 5q21 deletion is often heterogeneous in prostate cancer

    Kluth, M., Al Kilani, Z., Özden, C., Hussein, K., Frogh, S., Möller-Koop, C., Burandt, E., Steurer, S., Büscheck, F., Jacobsen, F., Luebke, A. M., Minner, S., Tsourlakis, M. C., Hoeflmayer, D., Wittmer, C., Schlomm, T., Sauter, G., Simon, R. & Wilczak, W., 08.2019, In: GENE CHROMOSOME CANC. 58, 8, p. 509-515 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Expression of the immune checkpoint receptor TIGIT in seminoma

    Hinsch, A., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S. & Wilczak, W., 08.2019, In: ONCOL LETT. 18, 2, p. 1497-1502 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

    Büscheck, F., Zub, M., Heumann, A., Hube-Magg, C., Simon, R., Lang, D. S., Höflmayer, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Sauter, G., Huland, H., Graefen, M., Haese, A., Heinzer, H., Schlomm, T., Clauditz, T. S., Burandt, E., Wilczak, W., Steurer, S. & Minner, S., 07.2019, In: TUMOR BIOL. 41, 7, p. 1010428318824815

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. SNW1 is a prognostic biomarker in prostate cancer

    Höflmayer, D., Willich, C., Hube-Magg, C., Simon, R., Lang, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Huland, H., Graefen, M., Haese, A., Heinzer, H., Minner, S., Büscheck, F., Sauter, G., Schlomm, T., Steurer, S., Clauditz, T. S., Burandt, E., Wilczak, W. & Bernreuther, C., 01.05.2019, In: DIAGN PATHOL. 14, 1, p. 33

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

    Luebke, A. M., Attarchi-Tehrani, A., Meiners, J., Hube-Magg, C., Lang, D. S., Kluth, M., Tsourlakis, M. C., Minner, S., Simon, R., Sauter, G., Büscheck, F., Jacobsen, F., Hinsch, A., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Clauditz, T. S., Burandt, E., Wilczak, W. & Höflmayer, D., 05.2019, In: CANCER BIOL MED. 16, 2, p. 319-330 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

    Schroeder, C., Grell, J., Hube-Magg, C., Kluth, M., Lang, D., Simon, R., Höflmayer, D., Minner, S., Burandt, E., Clauditz, T. S., Büscheck, F., Jacobsen, F., Huland, H., Graefen, M., Schlomm, T., Sauter, G. & Steurer, S., 01.03.2019, In: BMC CANCER. 19, 1, p. 193

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

    Eichenauer, T., Hussein, M., Hube-Magg, C., Kluth, M., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Steurer, S., Clauditz, T. S., Luebke, A. M., Burandt, E., Wilczak, W., Hinsch, A., Dum, D., Beyer, B., Steuber, T., Huland, H., Graefen, M., Simon, R., Sauter, G., Melling, N., Schlomm, T. & Minner, S., 01.03.2019, In: ONCOTARGET. 10, 18, p. 1729-1744 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy

    Marks, P., Gild, P., Soave, A., Janisch, F., Minner, S., Engel, O., Vetterlein, M. W., Shariat, S. F., Sauter, G., Dahlem, R., Fisch, M. & Rink, M., 03.2019, In: SURG ONCOL. 28, p. 208-213 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

    Minner, S., Lutz, J., Hube-Magg, C., Kluth, M., Simon, R., Höflmayer, D., Burandt, E., Tsourlakis, M. C., Sauter, G., Büscheck, F., Wilczak, W., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Jacobsen, F., Hinsch, A., Poos, A., Oswald, M., Rippe, K., König, R. & Schroeder, C., 02.2019, In: PROSTATE. 79, 3, p. 302-311 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

    Mandelkow, T., Blessin, N. C., Lueerss, E., Pott, L., Simon, R., Li, W., Wellge, B., Debatin, N. F., Höflmayer, D., Izbicki, J. R., Büscheck, F., Luebke, A. M., Wittmer, C., Jacobsen, F., Lutz, F., Burandt, E., Steurer, S., Sauter, G., Tsourlakis, M. C., Wilczak, W., Hinsch, A. & Minner, S., 2019, In: DIS MARKERS. 2019, p. 2532518

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

    Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E-C., Steurer, S., Wilczak, W. & Hinsch, A., 2019, In: DIS MARKERS. 2019, p. 5160565

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. 2018
  41. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

    Li, W., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Pott, L., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S., Wilczak, W. & Hinsch, A., 04.12.2018, In: BMC CANCER. 18, 1, p. 1209

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer

    Kluth, M., Scherzai, S., Büschek, F., Fraune, C., Möller, K., Höflmayer, D., Minner, S., Göbel, C., Möller-Koop, C., Hinsch, A., Neubauer, E., Tsourlakis, M. C., Sauter, G., Heinzer, H., Graefen, M., Wilczak, W., Luebke, A. M., Burandt, E., Steurer, S., Schlomm, T. & Simon, R., 10.2018, In: GENE CHROMOSOME CANC. 57, 10, p. 504-512 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

    Wilczak, W., Wittmer, C., Clauditz, T., Minner, S., Steurer, S., Büscheck, F., Krech, T., Lennartz, M., Harms, L., Leleu, D., Ahrens, M., Ingwerth, S., Günther, C. T., Koop, C., Simon, R., Jacobsen, F., Tsourlakis, M. C., Chirico, V., Höflmayer, D., Vettorazzi, E., Haese, A., Steuber, T., Salomon, G., Michl, U., Budäus, L., Tilki, D., Thederan, I., Fraune, C., Göbel, C., Henrich, M-C., Juhnke, M., Möller, K., Bawahab, A. A., Uhlig, R., Adam, M., Weidemann, S., Beyer, B., Huland, H., Graefen, M., Sauter, G. & Schlomm, T., 09.2018, In: EUR UROL. 74, 3, p. 376-386 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    Heumann, A., Kaya, Ö., Burdelski, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Beyer, B., Thederan, I., Sauter, G., Izbicki, J. R., Luebke, A. M., Hinsch, A., Jacobsen, F., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Schlomm, T. & Wilczak, W., 21.08.2018, In: SCI REP-UK. 8, 1, p. 12821

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  45. Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy."

    Soave, A., Riethdorf, S., Dahlem, R., Minner, S., Weisbach, L., Engel, O., Fisch, M., Pantel, K. & Rink, M., 07.2018, In: UROL ONCOL-SEMIN ORI. 36, 7, p. 347-348 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  46. Immunohistochemically detected IDH1 mutation is rare and mostly heterogeneous in prostate cancer

    Hinsch, A., Brolund, M., Hube-Magg, C., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Steurer, S., Luebke, A., Angerer, A., Wittmer, C., Neubauer, E., Göbel, C., Büscheck, F., Minner, S., Wilczak, W., Schlomm, T., Jacobsen, F., Clauditz, T. S., Krech, T., Tsourlakis, M. C. & Schroeder, C., 06.2018, In: WORLD J UROL. 36, 6, p. 877-882 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Sauter, G., Clauditz, T., Steurer, S., Wittmer, C., Büscheck, F., Krech, T., Lutz, F., Lennartz, M., Harms, L., Lawrenz, L., Möller-Koop, C., Simon, R., Jacobsen, F., Wilczak, W., Minner, S., Tsourlakis, M. C., Chirico, V., Weidemann, S., Haese, A., Steuber, T., Salomon, G., Matiu, M., Vettorazzi, E., Michl, U., Budäus, L., Tilki, D., Thederan, I., Pehrke, D., Beyer, B., Fraune, C., Göbel, C., Heinrich, M., Juhnke, M., Möller, K., Bawahab, A. A. A., Uhlig, R., Huland, H., Heinzer, H., Graefen, M. & Schlomm, T., 05.2018, In: EUR UROL. 73, 5, p. 674-683 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

    Heumann, A., Heinemann, N., Hube-Magg, C., Lang, D. S., Grupp, K., Kluth, M., Minner, S., Möller-Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wilczak, W., Wittmer, C., Jacobsen, F., Huland, H., Simon, R., Schlomm, T., Sauter, G., Steurer, S., Lebok, P. & Hinsch, A., 05.01.2018, In: BMC CANCER. 18, 1, p. 37

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor Features: A tissue microarray study on 8,877 human cancers and normal tissues

    Burdelski, C., Jakani-Karimi, N., Jacobsen, F., Möller-Koop, C., Minner, S., Simon, R., Sauter, G., Steurer, S., Clauditz, T. S. & Wilczak, W., 01.2018, In: ONCOL REP. 39, 1, p. 3-12 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

    Kluth, M., Volta, H., Hussein, M., Taskin, B., Frogh, S., Möller-Koop, C., Büscheck, F., Jacobsen, F., Tsourlakis, M. C., Lübke, A. M., Hinsch, A., Clauditz, T., Graefen, M., Heinzer, H., Huland, H., Minner, S., Sauter, G., Wilczak, W., Schlomm, T. & Simon, R., 2018, In: CANCER MANAG RES. 10, p. 5909-5917 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. 2017
  52. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

    Tsourlakis, M. C., Eleftheriadou, A., Stender, A., Weigand, P., Grupp, K., Hube-Magg, C., Kluth, M., Schroeder, C., Steurer, S., Hinsch, A., Luebke, A., Angerer, A., Wittmer, C., Friedrich, E., Göbel, C., Büscheck, F., Heinzer, H., Graefen, M., Simon, R., Sauter, G., Wilczak, W., Minner, S., Schlomm, T. & Jacobsen, F., 07.12.2017, In: CARCINOGENESIS. 38, 12, p. 1180-1187 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer

    Burdelski, C., Shihada, R., Hinsch, A., Angerer, A., Göbel, C., Friedrich, E., Hube-Magg, C., Burdak-Rothkamm, S., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Büscheck, F., Wittmer, C., Clauditz, T. S., Krech, T., Tsourlakis, M. C., Minner, S., Graefen, M., Schlomm, T., Wilczak, W. & Jacobsen, F., 11.2017, In: PROSTATE. 77, 15, p. 1528-1538 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

    Steurer, S., Rico, S. D., Simon, R., Minner, S., Tsourlakis, M. C., Krech, T., Koop, C., Graefen, M., Heinzer, H., Adam, M., Huland, H., Schlomm, T., Sauter, G. & Lumiani, A., 09.2017, In: BJU INT. 120, 3, p. 365-376 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review